MARKETS
Markets

Tempest Therapeutics Files Prospectus Related To The Offer And Sale Of Up To 8,910,579 Shares Of Common Stock

Aug 21, 2026 · 04:49 PM ET· updated 40m ago

-SEC Filing

Share
Why It Matters

Tempest Therapeutics is planning to sell more shares of its company to raise money. When a company does this, it means they need cash, but it can also dilute (spread out) what each share is worth.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.